| Genevieve-marie Ventarola, | |
|
91-1119 Kamaaha Loop, Kapolei, HI 96707-1973 | |
| (808) 305-8700 | |
| Not Available |
| Full Name | Genevieve-marie Ventarola |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 91-1119 Kamaaha Loop, Kapolei, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598422644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Genevieve-marie Ventarola, 99-039 Lohea Pl, Aiea, HI 96701-5409 Ph: (845) 662-5451 | Genevieve-marie Ventarola, 91-1119 Kamaaha Loop, Kapolei, HI 96707-1973 Ph: (808) 305-8700 |
News Archive
Devax, Inc. announced today the company received CE Mark for its AXXESS™ Biolimus A9® Eluting Coronary Bifurcation Stent System, allowing the company to initiate sales in the European Union and other countries that recognize the CE Mark.
Small and rural hospitals headed the list of top performing hospitals in using evidence-based processes closely linked to positive patient outcomes, according to the Joint Commission's annual report on quality and safety, Improving America's Hospitals.
An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting, and when such meetings occurred, pharmaceutical companies did not comply with one-quarter of the recommendations made by the FDA regarding study design or primary outcome, according to a study in the November 26 issue of JAMA.
The Feinstein Institute for Medical Research, the research arm of the North Shore-LIJ Health System, and SetPoint Medical Inc., a biomedical technology company, today released the results of research on the therapeutic potential of vagus nerve stimulation. In a paper published by Bioelectronic Medicine, Kevin J. Tracey, MD, and his colleagues at the Feinstein Institute, explore how low-level electrical stimulation interacts with the body's nerves to reduce inflammation, a fundamental goal of bioelectronic medicine.
› Verified 5 days ago
Ms. Emily A Shetler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 599 Farrington Hwy, Kapolei, HI 96707 Phone: 808-674-4006 Fax: 808-674-4007 | |
Ms. Hiromi O Dunn, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 575 Farrington Hwy, Kapolei, HI 96707 Phone: 808-674-9262 | |
Lela Angeline Mamrosh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 Boxer Rd, Kapolei, HI 96707 Phone: 808-707-0266 | |
Lydia Hill, MHS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 575 Farrington Hwy, Kapolei, HI 96707 Phone: 808-674-9262 | |
Sandra Walsh, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 575 Farrington Hwy, Kapolei, HI 96707 Phone: 808-674-4006 Fax: 808-674-4007 | |
Mrs. Ashley Isaza, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 92-461 Makakilo Dr, Kapolei, HI 96707 Phone: 808-536-1015 | |
Darlene Takahata, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 92-675 Anipeahi St, Kapolei, HI 96707 Phone: 808-672-1122 |